The 15 GTM ProblemsA Research-Backed Diagnostic Taxonomy of B2B Growth Stalls
A definitive classification of the 15 recurring failure modes that derail scaling companies across market focus, pipeline velocity, customer value, operations, and leadership.
Why GTM Challenges Collapse Into 15 Problem Patterns
When B2B companies experience growth stalls, leadership teams often describe their issues in dozens of disparate ways: *"Marketing isn’t driving enough pipeline," "Sales reps can’t close," "Customer Success is letting accounts churn,"* or *"The product roadmap is behind."*
Through qualitative research across hundreds of B2B executive leadership teams, GTM Partners discovered that GTM failure modes consistently collapse into the same 15 underlying root causes. These are not department problems; they are cross-functional system failures.
“You don’t have a sales problem, a marketing problem, or a CS problem. You have a go-to-market problem. Fixing departments in isolation never solves systemic growth stalls.”
The Complete 15 GTM Problems Taxonomy
Analyst relations don’t drive material impact
Diagnostic Symptom: Analyst coverage feels like PR expense without translating into buyer credibility, RFP inclusion, or shortened deal cycles.
Your competitors are winning more market share
Diagnostic Symptom: Stuck in feature parity while competitors set the narrative, resulting in pricing pressure and lost deal momentum.
Your Point of View is not differentiated with your product
Diagnostic Symptom: Your pitch sounds identical to 10 other vendors in the space; buyers perceive you as a generic commodity.
You are struggling to go from a product to a platform company
Diagnostic Symptom: New product add-ons fail to cross-sell; sales reps continue pitching the legacy core product.
Sales, Marketing, and Customer Success are out of sync
Diagnostic Symptom: Marketing claims lead goals are met, Sales complains about lead quality, and CS inherits customers with unrealistic expectations.
You can’t predict and forecast revenue for the next two quarters
Diagnostic Symptom: Deals push at quarter-end, pipeline coverage looks high but conversions are low, and leadership guesses at projections.
You can’t prioritize or say no to new initiatives
Diagnostic Symptom: Leadership pursues 15 disconnected growth ideas at once, diluting resources and burning out functional teams.
Your team is not aligned on an executive strategy
Diagnostic Symptom: Annual strategy sits in an unused 80-slide deck while functional departments operate on competing quarterly priorities.
Your churn is killing your business
Diagnostic Symptom: High gross churn and negative Net Revenue Retention erode new logo bookings, stalling total company growth.
You are the last to enter the deal cycle
Diagnostic Symptom: Prospects only contact you after defining their RFP with a competitor, forcing you into brutal price battles.
Your customers love you, but can’t quantify their ROI at renewal time
Diagnostic Symptom: Users enjoy using your tool, but the economic buyer cuts your budget during renewal audits.
Discounting and feature wars are eroding your value prop
Diagnostic Symptom: Sales reps routinely slash prices by 30-50% to close deals because they cannot defend economic value.
Your team is reactive, not proactive
Diagnostic Symptom: Leadership spends every week firefighting customer churn escalations and end-of-quarter pipeline shortfalls.
You want to go upmarket, but your current customers are smaller
Diagnostic Symptom: Attempts to sell enterprise deals stall because your product, sales motion, and support are designed for SMBs.
Your business is relying on heroic sales players and not plays
Diagnostic Symptom: Top 10% of reps hit 200% of quota while 70% of the team fails; revenue depends entirely on individual rockstars.
Audit Your Top 3 GTM Problems with an Expert
Gather your C-suite and functional leaders for a facilitated diagnostic workshop. Identify which of the 15 problems are actively stalling your revenue, and build a prioritized 90-day remediation roadmap.

